Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism
NCT02127840 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2014-05-01
Summary
The project is aimed to determine the value of synacthen infusion on the results of adrenal venous sampling in patients examined for primary aldosteronism
Conditions
- Primary Aldosteronism
Interventions
- DRUG
-
Synacthen infusion during adrenal venous sampling
Adrenal venous sampling during Synacthen infusion
Sponsors & Collaborators
-
University Hospital Hradec Kralove
collaborator OTHER -
Charles University, Czech Republic
lead OTHER
Principal Investigators
-
Jiri Ceral, MD · University Hospital Hradec Kralove
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-03-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
Countries
- Czechia
Study Locations
More Related Trials
-
A Study of Stimulant Medications Infusion Through Midline Catheters Based on Real-world Data
NCT06454552 ·Status: NOT_YET_RECRUITING
-
Helping Olfaction and Nutrition On Renal Replacement
NCT02479451 ·Status: COMPLETED ·Phase: PHASE2
-
Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole
NCT00268554 ·Status: COMPLETED ·Phase: NA
-
Influence on Erythropoetin-level by Xenon
NCT02129400 ·Status: TERMINATED ·Phase: PHASE3
-
Food-effect Study on Uracil and Dihydrouracil Levels as a Diagnostic Marker of Dihydropyrimidine Dehydrogenase Activity
NCT02718664 ·Status: COMPLETED ·Phase: NA
-
Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate
NCT02135965 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS)
NCT02959892 ·Status: COMPLETED ·Phase: PHASE1
-
DAnalysis of the Distribution of Adrenal Steroids in a Control Population
NCT04139447 ·Status: COMPLETED
-
Reproducibility of Acute Caffeine Effect
NCT06606639 ·Status: COMPLETED ·Phase: NA
-
Detection of Autologous DEHP (DiEthylHexyl Phthalate)-Free Blood Transfusion in Anti-doping
NCT02423135 ·Status: COMPLETED ·Phase: NA
-
Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia
NCT00253929 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Effects of Adderall in Healthy Adults.
NCT02979327 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Dietary Nitrate on Age-related Vascular Function
NCT01729234 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Beta2-adrenergic Agonism and Muscle Remodelling
NCT03565302 ·Status: UNKNOWN ·Phase: NA
-
Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development
NCT03775902 ·Status: COMPLETED ·Phase: NA
-
Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects
NCT02675660 ·Status: COMPLETED ·Phase: PHASE1
-
Creatine Monohydrate Use for Preventing Altitude Induced Depression
NCT03433651 ·Status: WITHDRAWN ·Phase: PHASE4
-
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide (NO) Homeostasis
NCT01137656 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Phenylephrine and Ephedrine on Microvascular Blood Flow
NCT02252627 ·Status: UNKNOWN
-
Caffeine and Resistance Training in Older Adults
NCT06618261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Role of K+ and Ca2+ in Development of Muscle Fatigue
NCT02712658 ·Status: COMPLETED ·Phase: NA
-
Response to Clenbuterol in Humans
NCT03860870 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of the Basel Phenotyping Cocktail Combination Capsule
NCT03247699 ·Status: COMPLETED ·Phase: NA
-
Study to Determine the Pharmacokinetics and Pharmacodynamic Effects of Phenylephrine on BP Via IV
NCT02323399 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Phenylephrine on Cardiac Preload
NCT02739399 ·Status: COMPLETED ·Phase: PHASE4